Publication | Closed Access

Novel Pyrazoloquinolin-2-ones: Design, synthesis, docking studies, and biological evaluation as antiproliferative EGFR-TK inhibitors

Medicinal ChemistryNovel Pyrazoloquinolin-2-onesMedicineRational Drug DesignPharmacological AgentPharmacotherapyBiological EvaluationAnti-cancer AgentDrug DevelopmentPharmacologyRadiation OncologyAntiproliferative Egfr-tk InhibitorsDrug Discovery